Cargando…

Effect of Plasmapheresis on Cholestatic Pruritus and Autotaxin Activity During Pregnancy

Detalles Bibliográficos
Autores principales:	Heerkens, Marieke, Dedden, Suzanne, Scheepers, Hubertina, Van Paassen, Pieter, Masclee, Ad, de Die‐Smulders, Christine, Olde Damink, Steven W.M., Schaap, Frank G., Jansen, Peter, Koek, Ger, Beuers, Ulrich, Verbeek, Jef
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Clinical Observations in Hepatology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593664/ https://www.ncbi.nlm.nih.gov/pubmed/30614557 http://dx.doi.org/10.1002/hep.30496

Ejemplares similares

Gut Microbes Take It to the Next Level? First Insights Into Farnesoid X Receptor Agonists of Microbial Origin
por: Lenicek, Martin, et al.
Publicado: (2020)

Hepatic autotaxin overexpression in infants with biliary atresia
por: Udomsinprasert, Wanvisa, et al.
Publicado: (2018)

Disease burden of primary biliary cholangitis and associated pruritus based on a cross-sectional US claims analysis
por: Gungabissoon, Usha, et al.
Publicado: (2022)

Colesevelam attenuates cholestatic liver and bile duct injury in Mdr2(−/−) mice by modulating composition, signalling and excretion of faecal bile acids
por: Fuchs, Claudia Daniela, et al.
Publicado: (2018)

Home-based exercise in patients with refractory fatigue associated with primary biliary cholangitis: a protocol for the EXerCise Intervention in cholesTatic LivEr Disease (EXCITED) feasibility trial
por: Freer, Alice, et al.
Publicado: (2021)

Cholestatic pruritus: a knowledge update()
por: Nietsche, Thaís Reginatto, et al.
Publicado: (2022)

Prevention of hepatic encephalopathy by administration of rifaximin and lactulose in patients with liver cirrhosis undergoing placement of a transjugular intrahepatic portosystemic shunt (TIPS): a multicentre randomised, double blind, placebo controlled trial (PEARL trial)
por: de Wit, K, et al.
Publicado: (2020)

Plasmapheresis for Refractory Pruritus due to Drug-Induced Cholestasis
por: Al-Azzawi, Hasan, et al.
Publicado: (2017)

Systematic review: efficacy of therapies for cholestatic pruritus
por: Ebhohon, Ebehiwele, et al.
Publicado: (2023)

Cholestatic Pruritus in Children: Conventional Therapies and Beyond
por: Rodrigo, Minna, et al.
Publicado: (2023)

Unaltered Liver Regeneration in Post-Cholestatic Rats Treated with the FXR Agonist Obeticholic Acid
por: de Haan, Lianne R., et al.
Publicado: (2021)

A novel prognostic model for transplant-free survival in primary sclerosing cholangitis
por: de Vries, Elisabeth M, et al.
Publicado: (2018)

Autotaxin, PPARs, and FGF21: An Eye Opener for Progressive Liver Disease?
por: Beuers, Ulrich, et al.
Publicado: (2022)

Efficacy of Treatments for Cholestatic Pruritus: A Systemic Review and Meta-analysis
por: DERVOUT, Charles, et al.
Publicado: (2022)

Intestinal permeability in human nonalcoholic fatty liver disease: A systematic review and meta‐analysis
por: De Munck, Toon J. I., et al.
Publicado: (2020)

Serum Autotaxin is a Marker of the Severity of Liver Injury and Overall Survival in Patients with Cholestatic Liver Diseases
por: Wunsch, Ewa, et al.
Publicado: (2016)

Pruritus in patients with chronic liver disease and serum autotaxin levels in patients with primary biliary cholangitis
por: Fujino, Hatsue, et al.
Publicado: (2019)

The role of bile acids in cholestatic liver injury
por: Cai, Shi-Ying, et al.
Publicado: (2021)

Novel Kappa-Opioid Receptor Agonist for the Treatment of Cholestatic Pruritus: Systematic Review
por: Bailey, Adrian Joseph Michel, et al.
Publicado: (2022)

NSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett's oesophagus: a population-based case–control study
por: Masclee, Gwen M C, et al.
Publicado: (2015)

Ileal Bile Acid Transporter Inhibition for the Treatment of Chronic Constipation, Cholestatic Pruritus, and NASH
por: Al-Dury, Samer, et al.
Publicado: (2018)

BAM8-22 and its receptor MRGPRX1 may attribute to cholestatic pruritus
por: Sanjel, Babina, et al.
Publicado: (2019)

Control Crohn Safe with episodic adalimumab monotherapy as first-line treatment study (CoCroS): study protocol for a randomised controlled trial
por: Janssen, Laura, et al.
Publicado: (2021)

Pilot study with IBAT inhibitor A4250 for the treatment of cholestatic pruritus in primary biliary cholangitis
por: Al-Dury, Samer, et al.
Publicado: (2018)

Cholestasis-Associated Pruritus and Its Pruritogens
por: Langedijk, Jacqueline A. G. M., et al.
Publicado: (2021)

Effectiveness and safety of metoclopramide in treatment of intractable hiccup: a protocol of systematic review and meta-analysis
por: Wang, Die, et al.
Publicado: (2022)

Autotaxin activity predicts transplant-free survival in primary sclerosing cholangitis
por: Dhillon, Amandeep K., et al.
Publicado: (2019)

Rifampicin for Treatment of Cholestatic Pruritus Caused by Drug-Induced Acute Liver Injury as Assessed by the RUCAM Classification
por: Ahmadi, Ali R., et al.
Publicado: (2020)

Cholestatic Pruritus Treatments in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: A Systematic Literature Review
por: Smith, Helen T., et al.
Publicado: (2023)

The Investigation of Therapeutic Implications of Mast Cell Stabilizer Cromolyn Sodium on Cholestasis and Cholestatic Pruritus in Experimental Cholestasis
por: Yurdakul Ertan, Hanife, et al.
Publicado: (2023)

Fast-food-based hyper-alimentation can induce rapid and profound elevation of serum alanine aminotransferase in healthy subjects
por: Kechagias, S, et al.
Publicado: (2008)

Costs and cost-effectiveness of different follow-up schedules for detection of occupational hepatitis C virus infection
por: Deuffic-Burban, S, et al.
Publicado: (2008)

Risk factors for acute hepatitis B and its progression to chronic hepatitis in Shanghai, China
por: Zhang, H W, et al.
Publicado: (2008)

Molecular footprints reveal the impact of the protective HLA-A*03 allele in hepatitis C virus infection
por: Fitzmaurice, Karen, et al.
Publicado: (2011)

Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss
por: Hallsworth, Kate, et al.
Publicado: (2011)

Impaired plasmacytoid dendritic cell maturation and differential chemotaxis in chronic hepatitis C virus: associations with antiviral treatment outcomes
por: Mengshol, J A, et al.
Publicado: (2009)

Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma
por: Chew, Valerie, et al.
Publicado: (2011)

Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men
por: Thomson, Emma C, et al.
Publicado: (2010)

Cleavage of the IPS-1/Cardif/MAVS/VISA does not inhibit T cell-mediated elimination of hepatitis C virus non-structural 3/4A-expressing hepatocytes
por: Ahlén, G, et al.
Publicado: (2009)

The paradox of NKp46(+) natural killer cells: drivers of severe hepatitis C virus-induced pathology but in-vivo resistance to interferon α treatment
por: Pembroke, Tom, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_iu0stjm8o02qnabbq1it2kdq3h